Artificial Respiration

The FDA has issued a class 1 recall of Centurion Medical Products’ airway kits containing Sheridan Endotracheal Tubes used when patients cannot maintain sufficient respiratory function.

New data from the PHARLAP trial indicated that a maximal lung recruitment strategy, compared with conventional mechanical ventilation, had no effect on the number of ventilator-free days or mortality in patients with acute respiratory distress syndrome.